GP
Insider
GSK plc
10% ownerGSK plc (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in WVE. Across 1 priced purchase filing, the average 21-session return was -29.8% from execution and -13.4% from disclosure (delay-adjusted; derived). The largest single filing was $27.9M of WVE (1,470,000 sh × $19.00, as filed), executed Dec 11 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-29.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-13.4%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$27.9M
shares × price, as filed
Last traded
Dec 11 2025
Filed Dec 15 2025
Volume by month
Buys $50.3M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 12 months
Most traded names
WVE
WVE
WVE · 2 buys · 0 sells
2 filings
Recent filings
WVEPURCHASE
Wave Life Sciences Ltd.
View filing →
$27.9M1,470,000 sh × $19.00
Exec Dec 11 2025
Filed Dec 15 2025 · 4:32 PM ET WVEPURCHASE Wave Life Sciences Ltd. View filing → $22.3M
2,791,930 sh × $8.00
Exec Sep 27 2024
Filed Oct 1 2024 · 5:30 PM ET